Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia

Leuk Lymphoma. 2024 Dec 24:1-3. doi: 10.1080/10428194.2024.2444466. Online ahead of print.

Malin S Nilsson^{1

2}, Anna Martner^{1

2}, Lovisa Wennström³, Markus Hansson³, Fredrik B Thorén^{1

4}, Kristoffer Hellstrand^{1

5}

¹ TIMM laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.
² Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
³ Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁴ Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁵ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

No abstract available